Alamar Biosciences IPO

Alamar Biosciences is a biotechnology company that is striving to develop a precision proteomics platform that is used in protein biomarker detection. Their flagship technology platform is called NULISA (Nanoparticle Uninhibited Luminescent Immunoassay), and it aims to help researchers detect protein biomarkers down to attomolar concentrations, or extremely small amounts. Alamar Biosciences seeks to use the NULISA platform to increase the speed of development for new diagnostic tests that can detect diseases early and improve treatment options. Alamar Biosciences founded in 2018 and headquartered in Fremont, CA.

Register for Details

For more details on financing and valuation for Alamar Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Alamar Biosciences

Forge green plus iconForge green minus icon

What is Alamar Biosciences's IPO price?

The IPO price for Alamar Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Alamar Biosciences?

Alamar Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Alamar Biosciences shares pre-IPO?

If you own Alamar Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Alamar Biosciences a publicly traded company?

Alamar Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Alamar Biosciences's funding to date?

Alamar Biosciences has raised $248.57MM to date.
Forge green plus iconForge green minus icon

When was Alamar Biosciences founded?

Alamar Biosciences was founded in 2018.

Who are Alamar Biosciences's major investors?

Qiming Venture Partners
Sherpa Healthcare Partners
Hercules Capital
Morningside Group
Samsara Biocapital
National Institutes of Health
Sands Capital
U.S. Department of Health and Human Services
Illumina Ventures
Terra Magnum Capital Partners

Alamar Biosciences Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/26/2024 Series C $128.27MM raised $XXX.XX $XXX.XX
10/15/2021 Series B-Plus $10MM raised $XXX.XX $XXX.XX
9/8/2021 Series B $80MM raised $XXX.XX $XXX.XX
5/26/2020 Series A-1, A-2, A-3 and A-4 $30.3MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 18, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.